We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Walgreens Boots Alliance (WBA) Stock Moves -0.65%: What You Should Know
Read MoreHide Full Article
Walgreens Boots Alliance (WBA - Free Report) closed at $49.22 in the latest trading session, marking a -0.65% move from the prior day. This change lagged the S&P 500's daily of 0%.
Heading into today, shares of the largest U.S. drugstore chain had gained 1.27% over the past month, lagging the Retail-Wholesale sector's gain of 7.25% and the S&P 500's gain of 7.79% in that time.
Wall Street will be looking for positivity from WBA as it approaches its next earnings report date. In that report, analysts expect WBA to post earnings of $1.14 per share. This would mark a year-over-year decline of 6.56%. Meanwhile, our latest consensus estimate is calling for revenue of $33.28 billion, down 8.33% from the prior-year quarter.
WBA's full-year Zacks Consensus Estimates are calling for earnings of $4.96 per share and revenue of $132.41 billion. These results would represent year-over-year changes of -6.59% and -3.61%, respectively.
Investors might also notice recent changes to analyst estimates for WBA. These revisions help to show the ever-changing nature of near-term business trends. As such, positive estimate revisions reflect analyst optimism about the company's business and profitability.
Based on our research, we believe these estimate revisions are directly related to near-team stock moves. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Over the past month, the Zacks Consensus EPS estimate has moved 1.94% lower. WBA is currently sporting a Zacks Rank of #4 (Sell).
In terms of valuation, WBA is currently trading at a Forward P/E ratio of 9.99. This valuation marks a no noticeable deviation compared to its industry's average Forward P/E of 9.99.
Investors should also note that WBA has a PEG ratio of 2.26 right now. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. WBA's industry had an average PEG ratio of 2.01 as of yesterday's close.
The Retail - Pharmacies and Drug Stores industry is part of the Retail-Wholesale sector. This industry currently has a Zacks Industry Rank of 246, which puts it in the bottom 4% of all 250+ industries.
The Zacks Industry Rank includes is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
To follow WBA in the coming trading sessions, be sure to utilize Zacks.com.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Walgreens Boots Alliance (WBA) Stock Moves -0.65%: What You Should Know
Walgreens Boots Alliance (WBA - Free Report) closed at $49.22 in the latest trading session, marking a -0.65% move from the prior day. This change lagged the S&P 500's daily of 0%.
Heading into today, shares of the largest U.S. drugstore chain had gained 1.27% over the past month, lagging the Retail-Wholesale sector's gain of 7.25% and the S&P 500's gain of 7.79% in that time.
Wall Street will be looking for positivity from WBA as it approaches its next earnings report date. In that report, analysts expect WBA to post earnings of $1.14 per share. This would mark a year-over-year decline of 6.56%. Meanwhile, our latest consensus estimate is calling for revenue of $33.28 billion, down 8.33% from the prior-year quarter.
WBA's full-year Zacks Consensus Estimates are calling for earnings of $4.96 per share and revenue of $132.41 billion. These results would represent year-over-year changes of -6.59% and -3.61%, respectively.
Investors might also notice recent changes to analyst estimates for WBA. These revisions help to show the ever-changing nature of near-term business trends. As such, positive estimate revisions reflect analyst optimism about the company's business and profitability.
Based on our research, we believe these estimate revisions are directly related to near-team stock moves. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Over the past month, the Zacks Consensus EPS estimate has moved 1.94% lower. WBA is currently sporting a Zacks Rank of #4 (Sell).
In terms of valuation, WBA is currently trading at a Forward P/E ratio of 9.99. This valuation marks a no noticeable deviation compared to its industry's average Forward P/E of 9.99.
Investors should also note that WBA has a PEG ratio of 2.26 right now. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. WBA's industry had an average PEG ratio of 2.01 as of yesterday's close.
The Retail - Pharmacies and Drug Stores industry is part of the Retail-Wholesale sector. This industry currently has a Zacks Industry Rank of 246, which puts it in the bottom 4% of all 250+ industries.
The Zacks Industry Rank includes is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
To follow WBA in the coming trading sessions, be sure to utilize Zacks.com.